Cargando…

Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition

P-glycoprotein (P-gp, ABCB1) over-expression, causing a multi-drug resistant (MDR) phenotype, is a major problem in cancer chemotherapy that urgently requires novel approaches. Our previous studies showed certain ecdysteroid derivatives as promising chemo-sensitizers against MDR and non-MDR cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hunyadi, Attila, Csábi, József, Martins, Ana, Molnár, Joseph, Balázs, Attila, Tóth, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155823/
https://www.ncbi.nlm.nih.gov/pubmed/28125071
http://dx.doi.org/10.3390/molecules22020199
_version_ 1783357974275686400
author Hunyadi, Attila
Csábi, József
Martins, Ana
Molnár, Joseph
Balázs, Attila
Tóth, Gábor
author_facet Hunyadi, Attila
Csábi, József
Martins, Ana
Molnár, Joseph
Balázs, Attila
Tóth, Gábor
author_sort Hunyadi, Attila
collection PubMed
description P-glycoprotein (P-gp, ABCB1) over-expression, causing a multi-drug resistant (MDR) phenotype, is a major problem in cancer chemotherapy that urgently requires novel approaches. Our previous studies showed certain ecdysteroid derivatives as promising chemo-sensitizers against MDR and non-MDR cancer cell lines while also exerting mild to moderate inhibition of P-gp function. Here we report the preparation of a set of substituted 2,3-dioxolane derivatives of poststerone, a known in vivo metabolite of 20-hydroxyecdysone (20E). In contrast with previously studied ecdysteroid dioxolanes, the majority of the new compounds did not inhibit the efflux function of P-gp. Nevertheless, a strong, dose dependent sensitization to doxorubicin was observed on a P-gp transfected cancer cell line and on its susceptible counterpart. We also observed that the MDR cell line was more sensitive to the compounds’ effect than the non-MDR. Our results showed for the first time that the chemo-sensitizing activity of ecdysteroids can be fully independent of functional efflux pump inhibition, and suggest these compounds as favorable leads against MDR cancer.
format Online
Article
Text
id pubmed-6155823
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61558232018-11-13 Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition Hunyadi, Attila Csábi, József Martins, Ana Molnár, Joseph Balázs, Attila Tóth, Gábor Molecules Article P-glycoprotein (P-gp, ABCB1) over-expression, causing a multi-drug resistant (MDR) phenotype, is a major problem in cancer chemotherapy that urgently requires novel approaches. Our previous studies showed certain ecdysteroid derivatives as promising chemo-sensitizers against MDR and non-MDR cancer cell lines while also exerting mild to moderate inhibition of P-gp function. Here we report the preparation of a set of substituted 2,3-dioxolane derivatives of poststerone, a known in vivo metabolite of 20-hydroxyecdysone (20E). In contrast with previously studied ecdysteroid dioxolanes, the majority of the new compounds did not inhibit the efflux function of P-gp. Nevertheless, a strong, dose dependent sensitization to doxorubicin was observed on a P-gp transfected cancer cell line and on its susceptible counterpart. We also observed that the MDR cell line was more sensitive to the compounds’ effect than the non-MDR. Our results showed for the first time that the chemo-sensitizing activity of ecdysteroids can be fully independent of functional efflux pump inhibition, and suggest these compounds as favorable leads against MDR cancer. MDPI 2017-01-25 /pmc/articles/PMC6155823/ /pubmed/28125071 http://dx.doi.org/10.3390/molecules22020199 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hunyadi, Attila
Csábi, József
Martins, Ana
Molnár, Joseph
Balázs, Attila
Tóth, Gábor
Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
title Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
title_full Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
title_fullStr Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
title_full_unstemmed Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
title_short Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition
title_sort backstabbing p-gp: side-chain cleaved ecdysteroid 2,3-dioxolanes hyper-sensitize mdr cancer cells to doxorubicin without efflux inhibition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155823/
https://www.ncbi.nlm.nih.gov/pubmed/28125071
http://dx.doi.org/10.3390/molecules22020199
work_keys_str_mv AT hunyadiattila backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition
AT csabijozsef backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition
AT martinsana backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition
AT molnarjoseph backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition
AT balazsattila backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition
AT tothgabor backstabbingpgpsidechaincleavedecdysteroid23dioxolaneshypersensitizemdrcancercellstodoxorubicinwithouteffluxinhibition